Morphophenotypic predictor of the development of visceral obesity in patients with schizophrenia receiving antipsychotic therapy

Objective: revealing the role of morphophenotypic indices in the development of visceral obesity in patients with schizophrenia receiving quetiapine and risperidone therapy.Materials and methods. 56 indoor patients with schizophrenia who received quetiapine (n = 23) or risperidone (n = 33) at medium...

Full description

Saved in:
Bibliographic Details
Main Authors: E. G. Kornetova, V. V. Dubrovskaya, A. N. Kornetov, O. A. Lobacheva, S. A. Ivanova, A. V. Semke
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2018-12-01
Series:Бюллетень сибирской медицины
Subjects:
Online Access:https://bulletin.ssmu.ru/jour/article/view/1978
Tags: Add Tag
No Tags, Be the first to tag this record!